4 drug(s) with this reaction
41,841 total reports
Crohn S Disease has been reported as an adverse reaction across 4 drug(s) manufactured by Abbvie Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 41,841 adverse event reports mention crohn s disease in connection with Abbvie Inc products.
This page provides a breakdown of which Abbvie Inc drugs are most commonly associated with crohn s disease, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Abbvie Inc drugs have crohn s disease listed in their FDA adverse event reports, sorted by report count:
In addition to crohn s disease, the following adverse reactions have been reported across Abbvie Inc's drug portfolio:
4 drug(s) manufactured by Abbvie Inc have crohn s disease listed in their FDA adverse event reports: Humira, ADALIMUMAB, RISANKIZUMAB-RZAA, UPADACITINIB.
There are a combined 41,841 reports of crohn s disease across 4 Abbvie Inc drug(s) in the FDA adverse event database.